Posted 1/22/2025 19:19 (#11068919 - in reply to #11068870) Subject: RE: Abbvie
Patent ran up on humira but they have two other drugs they’re selling I think that are supposed to make up for it. . The P/E ratio is so high but I kinda like the chart. Which led me to dcf and the dcf I saw showed it to be undervalued. I do not know about their pipeline and what drugs they are waiting to get approved tho
Oracle ceo sells 300 million?
